Related Experiment Videos
Diagnostic molecular markers in thyroid cancer.
1Department of Medicine, Division of Endocrinology, The Ohio State University, Columbus, Ohio, USA.
Cancer Treatment and Research
|October 8, 2005
Summary
Molecular assays show promise for thyroid cancer diagnosis and recurrence detection. Challenges remain in quantifying results and diagnosing distant metastases due to gene expression variability.
Area of Science:
- Oncology
- Molecular Diagnostics
- Genomics
Background:
- Molecular assays offer improved characterization of tumor aggressiveness and early recurrence detection in thyroid cancer.
- Application to thyroid nodules and nodal metastases is promising due to fewer issues with non-thyroid cell transcript amplification.
Purpose of the Study:
- To evaluate the clinical applicability of molecular assays in thyroid cancer diagnosis and management.
- To identify challenges and areas for future research in molecular assay development for thyroid cancer.
Main Methods:
- Analysis of clinical tissues using molecular assays, including cDNA arrays.
- Investigating gene expression patterns and potential novel markers for malignancy and aggressiveness.
Main Results:
- Assays are nearing clinical applicability for thyroid nodules and nodal metastases.
- Diagnosis of distant metastases is complicated by ectopic gene expression.
- Assay quantitation faces challenges due to "housekeeping" gene variability and diverse methodologies.
Conclusions:
- Molecular assays are poised for near-future clinical use in specific thyroid cancer contexts.
- Further research is essential to overcome quantitation and distant metastasis diagnostic hurdles.
- Standardization of methods and validation are crucial for widespread clinical adoption.